Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.35B | 55.53B | 52.61B | 50.84B | 48.21B | 49.50B |
Gross Profit | 16.09B | 15.43B | 15.40B | 14.12B | 14.19B | 13.64B |
EBITDA | 3.04B | 3.06B | 3.70B | 2.11B | 2.97B | 3.38B |
Net Income | 1.51B | 510.81M | 1.07B | 9.90M | 741.10M | 1.22B |
Balance Sheet | ||||||
Total Assets | 51.89B | 59.05B | 57.61B | 54.91B | 52.76B | 53.80B |
Cash, Cash Equivalents and Short-Term Investments | 12.75B | 13.93B | 12.34B | 12.21B | 13.53B | 12.73B |
Total Debt | 3.01B | 2.95B | 3.36B | 3.63B | 3.18B | 3.20B |
Total Liabilities | 16.50B | 15.85B | 16.03B | 15.31B | 14.24B | 17.29B |
Stockholders Equity | 32.51B | 40.89B | 39.26B | 36.66B | 35.79B | 33.87B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.98B | 1.50B | -758.81M | 1.27B | 358.29M |
Operating Cash Flow | 0.00 | 3.28B | 3.28B | 951.64M | 2.58B | 1.59B |
Investing Cash Flow | 0.00 | -1.53B | -1.23B | -1.18B | -811.51M | -1.08B |
Financing Cash Flow | 0.00 | -1.92B | -2.30B | -1.24B | -922.64M | -381.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥381.22B | 34.68 | 4.48% | 13.59% | 24.32% | ||
77 Outperform | ¥10.91B | 9.35 | 6.25% | 6.57% | 32.39% | ||
74 Outperform | ¥33.60B | 3.58 | 4.13% | 0.79% | 104.86% | ||
74 Outperform | $129.96B | 10.72 | 6.65% | 1.41% | 5.21% | -9.31% | |
70 Neutral | ¥175.70B | 11.17 | 6.37% | 3.52% | 3.93% | 6.03% | |
67 Neutral | ¥16.48B | 32.47 | 3.27% | 5.54% | -52.06% | ||
66 Neutral | ¥6.48B | 8.98 | 3.51% | 0.26% | 82.94% |